Sashidhar Nakerakanti
Postdoctoral Fellow
Boston University Medical Campus
Dept of Rheumatology



Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Rice LM, Padilla CM, McLaughlin SR, Mathes A, Ziemek J, Goummih S, Nakerakanti S, York M, Farina G, Whitfield ML, Spiera RF, Christmann RB, Gordon JK, Weinberg J, Simms RW, Lafyatis R. Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients. J Clin Invest. 2015 Jul 1; 125(7):2795-807.View Related Profiles. PMID: 26098215; PMCID: PMC4563675; DOI: 10.1172/JCI77958;.
  2. Stifano G, Affandi AJ, Mathes AL, Rice LM, Nakerakanti S, Nazari B, Lee J, Christmann RB, Lafyatis R. Chronic Toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expression, and fibrosis. Arthritis Res Ther. 2014; 16(4):R136.View Related Profiles. PMID: 24984848; PMCID: PMC4227089; DOI: 10.1186/ar4598;.
  3. Nakerakanti S, Trojanowska M. The Role of TGF-ß Receptors in Fibrosis. Open Rheumatol J. 2012; 6:156-62.View Related Profiles. PMID: 22802914; PMCID: PMC3396054; DOI: 10.2174/1874312901206010156;.
  4. Nakerakanti SS, Bujor AM, Trojanowska M. CCN2 is required for the TGF-ß induced activation of Smad1-Erk1/2 signaling network. PLoS One. 2011; 6(7):e21911.View Related Profiles. PMID: 21760921; PMCID: PMC3132735; DOI: 10.1371/journal.pone.0021911;.
  5. Hattori T, Stawski L, Nakerakanti SS, Trojanowska M. Fli1 is a negative regulator of estrogen receptor a in dermal fibroblasts. J Invest Dermatol. 2011 Jul; 131(7):1469-76.View Related Profiles. PMID: 21451544; PMCID: PMC3825457; DOI: 10.1038/jid.2011.63;.
  6. Markiewicz M, Nakerakanti SS, Kapanadze B, Ghatnekar A, Trojanowska M. Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells. Microcirculation. 2011 Jan; 18(1):1-11.View Related Profiles. PMID: 21166920; PMCID: PMC3058265; DOI: 10.1111/j.1549-8719.2010.00058.x;.
  7. Samuel GH, Bujor AM, Nakerakanti SS, Hant FN, Trojanowska M. Autocrine transforming growth factor ß signaling regulates extracellular signal-regulated kinase 1/2 phosphorylation via modulation of protein phosphatase 2A expression in scleroderma fibroblasts. Fibrogenesis Tissue Repair. 2010; 3:25.View Related Profiles. PMID: 21134273; PMCID: PMC3008687; DOI: 10.1186/1755-1536-3-25;.
  8. Wang B, Carter RE, Jaffa MA, Nakerakanti S, Lackland D, Lopes-Virella M, Trojanowska M, Luttrell LM, Jaffa AA. Genetic variant in the promoter of connective tissue growth factor gene confers susceptibility to nephropathy in type 1 diabetes. J Med Genet. 2010 Jun; 47(6):391-7.View Related Profiles. PMID: 20522428; PMCID: PMC3828650; DOI: 10.1136/jmg.2009.073098;.
  9. Bujor AM, Nakerakanti S, Morris E, Hant FN, Trojanowska M. Akt inhibition up-regulates MMP1 through a CCN2-dependent pathway in human dermal fibroblasts. Exp Dermatol. 2010 Apr; 19(4):347-54.View Related Profiles. PMID: 20201953; PMCID: PMC3826663; DOI: 10.1111/j.1600-0625.2010.01065.x;.
  10. Pannu J, Asano Y, Nakerakanti S, Smith E, Jablonska S, Blaszczyk M, ten Dijke P, Trojanowska M. Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate. Arthritis Rheum. 2008 Aug; 58(8):2528-37.View Related Profiles. PMID: 18668566; DOI: 10.1002/art.23698;.
Showing 10 of 12 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 12 publications over 8 distinct years, with a maximum of 3 publications in 2010 and 2011

YearPublications
20061
20071
20081
20103
20113
20121
20141
20151
Contact for Mentoring:


72 E. Concord St Evans Building
Boston MA 02118
Google Map


Nakerakanti's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department